Skip to Content
AbbVie started 2021 strong, surpassing first-quarter earnings and revenue estimates. The Chicago-based pharmaceutical company saw a revenue increase in the first quarter from its primary breadwinner, Humira, in the U.S. The drug has faced steep competition globally from biosimilars, but AbbVie made up for it with increased sales from recently released plaque psoriasis drug Skyrizi and treatment for severe rheumatoid arthritis, Rinvoq. The two drugs made $2.3 billion just 12 months after being released. In 2019 AbbVie acquired Allergan for an eye-popping $63 billion and is now starting to reap the benefits. Allergan’s products, which includes Botox, made up almost 20% of AbbVie’s 2020 revenue.
Lists ranking AbbVie
RANK68
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
RANK58
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
RANK3
20 Best Workplaces in Biotechnology and Pharmaceuticals - 2021The best U.S. biotechnology and pharmaceutical com...READ MOREview in list
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
RANK15
World’s 25 Best Workplaces - 2020Companies on this year's list earned national reco...READ MOREview in list
RANK67
75 Best Large Workplaces for Women - 2020The companies on this year's list make a conscious...READ MOREview in list
RANK378
Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list
RANK43
75 Best Large Workplaces for Millennials - 2020We surveyed tens of thousands of young employees t...READ MOREview in list